Related Experiment Video
Updated: Sep 24, 2025

Evaluating Autophagy Levels in Two Different Pancreatic Cell Models Using LC3 Immunofluorescence
Published on: April 28, 2023
L3MBTL2-mediated CGA transcriptional suppression promotes pancreatic cancer progression through modulating autophagy
Hua Huang1, Ruining Pan1, Yue Zhao2
1Center of Excellence for Environmental Safety and Biological Effects, Beijing International Science and Technology Cooperation Base for Antiviral Drugs, Faculty of Environment and Life, Beijing University of Technology, Beijing 100124, China.
Abstract:
L3MBTL2 is a crucial component of ncPRC1.6 and has been implicated in transcriptional repression and chromatin compaction. However, the repression mechanism of L3MBTL2 and its biological functions are largely undefined. Here, we found that L3MBTL2 plays a distinct oncogenic role in tumor development. We demonstrated that L3MBTL2 repressed downstream CGA through an H2AK119ub1-dependent mechanism. Importantly, the binding of the MGA/MAX heterodimer to the E-box on the CGA promoter enhanced the specific selective repression of CGA by L3MBTL2. CGA encodes the alpha subunit of glycoprotein hormones; however, we showed that CGA plays an individual tumor suppressor role in PDAC. Moreover, CGA-transcript1 (T1) was identified as the major transcript, and the tumor suppression function of CGA-T1 depends on its own glycosylation. Furthermore, glycosylated CGA-T1 inhibited PDAC, partly by repression of autophagy through multiple pathways, including PI3K/Akt/mTOR and TP53INP2 pathways. These findings reveal the important roles of L3MBTL2 and CGA in tumor development.
Insights
L3MBTL2 promotes tumor development by repressing the tumor suppressor CGA. Glycosylated CGA-transcript1 inhibits pancreatic ductal adenocarcinoma (PDAC) by suppressing autophagy.
Area of Science:
- Molecular Biology
- Cancer Biology
- Epigenetics
Background:
- L3MBTL2 is a component of ncPRC1.6, involved in transcriptional repression and chromatin compaction.
- The precise repression mechanisms and biological functions of L3MBTL2 remain largely undefined.
- Understanding L3MBTL2's role is crucial for elucidating its oncogenic potential.
Purpose of the Study:
- To investigate the oncogenic role of L3MBTL2 in tumor development.
- To elucidate the mechanism by which L3MBTL2 represses downstream targets.
- To determine the tumor suppressor function of CGA and its transcript variants in pancreatic ductal adenocarcinoma (PDAC).
Main Methods:
- Chromatin immunoprecipitation (ChIP) assays to assess protein-DNA interactions.
- Quantitative real-time PCR (qRT-PCR) to measure gene expression levels.
- Western blotting to detect protein levels and post-translational modifications.
- Cellular assays to evaluate autophagy inhibition and tumor suppressor activity.
Main Results:
- L3MBTL2 was found to play a distinct oncogenic role in tumor development.
- L3MBTL2 repressed the downstream gene CGA via an H2AK119ub1-dependent mechanism.
- The MGA/MAX heterodimer enhanced L3MBTL2's selective repression of CGA.
- CGA, particularly CGA-transcript1 (T1), exhibited tumor suppressor activity in PDAC.
- Glycosylated CGA-T1 inhibited PDAC by repressing autophagy through PI3K/Akt/mTOR and TP53INP2 pathways.
Conclusions:
- L3MBTL2 acts as an oncogene by repressing the tumor suppressor CGA.
- CGA-T1 possesses tumor suppressor functions in PDAC, mediated by glycosylation and autophagy inhibition.
- These findings highlight the critical roles of L3MBTL2 and CGA in cancer development and progression.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
Cell Specific Gene Expression
PI3K/mTOR/AKT Signaling Pathway
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Induced Pluripotent Stem Cells
Somatic...

